Previous close | 90.60 |
Open | 90.68 |
Bid | 90.09 x 100 |
Ask | 116.22 x 200 |
Day's range | 89.86 - 90.97 |
52-week range | 36.42 - 99.63 |
Volume | |
Avg. volume | 739,891 |
Market cap | 2.96B |
Beta (5Y monthly) | 1.98 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.77 |
Earnings date | 29 Apr 2024 - 03 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 99.40 |
LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strong global new customer starts fueled by the ongoing Omnipod 5 demand are expected to significantly benefit Insulet's (PODD) first-quarter performance.
TransMedics (TMDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.